Chapter/Section Purchase

1 Study Coverage
1.1 Irbesartan Product Introduction
1.2 Market by Type
1.2.1 Global Irbesartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Market by Application
1.3.1 Global Irbesartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hyperlipidemia
1.3.3 High Blood Pressure
1.3.4 Heart Failure
1.3.5 Kidney Disease
1.3.6 Fibrous Fibrillation
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Irbesartan Sales Estimates and Forecasts 2017-2028
2.2 Global Irbesartan Revenue Estimates and Forecasts 2017-2028
2.3 Global Irbesartan Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Irbesartan Sales by Region
2.4.1 Global Irbesartan Sales by Region (2017-2022)
2.4.2 Global Sales Irbesartan by Region (2023-2028)
2.5 Global Irbesartan Revenue by Region
2.5.1 Global Irbesartan Revenue by Region (2017-2022)
2.5.2 Global Irbesartan Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Irbesartan Sales by Manufacturers
3.1.1 Global Top Irbesartan Manufacturers by Sales (2017-2022)
3.1.2 Global Irbesartan Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Irbesartan in 2021
3.2 Global Irbesartan Revenue by Manufacturers
3.2.1 Global Irbesartan Revenue by Manufacturers (2017-2022)
3.2.2 Global Irbesartan Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Irbesartan Revenue in 2021
3.3 Global Irbesartan Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Irbesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Irbesartan Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Irbesartan Sales by Type
4.1.1 Global Irbesartan Historical Sales by Type (2017-2022)
4.1.2 Global Irbesartan Forecasted Sales by Type (2023-2028)
4.1.3 Global Irbesartan Sales Market Share by Type (2017-2028)
4.2 Global Irbesartan Revenue by Type
4.2.1 Global Irbesartan Historical Revenue by Type (2017-2022)
4.2.2 Global Irbesartan Forecasted Revenue by Type (2023-2028)
4.2.3 Global Irbesartan Revenue Market Share by Type (2017-2028)
4.3 Global Irbesartan Price by Type
4.3.1 Global Irbesartan Price by Type (2017-2022)
4.3.2 Global Irbesartan Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Irbesartan Sales by Application
5.1.1 Global Irbesartan Historical Sales by Application (2017-2022)
5.1.2 Global Irbesartan Forecasted Sales by Application (2023-2028)
5.1.3 Global Irbesartan Sales Market Share by Application (2017-2028)
5.2 Global Irbesartan Revenue by Application
5.2.1 Global Irbesartan Historical Revenue by Application (2017-2022)
5.2.2 Global Irbesartan Forecasted Revenue by Application (2023-2028)
5.2.3 Global Irbesartan Revenue Market Share by Application (2017-2028)
5.3 Global Irbesartan Price by Application
5.3.1 Global Irbesartan Price by Application (2017-2022)
5.3.2 Global Irbesartan Price Forecast by Application (2023-2028)
6 North America
6.1 North America Irbesartan Market Size by Type
6.1.1 North America Irbesartan Sales by Type (2017-2028)
6.1.2 North America Irbesartan Revenue by Type (2017-2028)
6.2 North America Irbesartan Market Size by Application
6.2.1 North America Irbesartan Sales by Application (2017-2028)
6.2.2 North America Irbesartan Revenue by Application (2017-2028)
6.3 North America Irbesartan Market Size by Country
6.3.1 North America Irbesartan Sales by Country (2017-2028)
6.3.2 North America Irbesartan Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Irbesartan Market Size by Type
7.1.1 Europe Irbesartan Sales by Type (2017-2028)
7.1.2 Europe Irbesartan Revenue by Type (2017-2028)
7.2 Europe Irbesartan Market Size by Application
7.2.1 Europe Irbesartan Sales by Application (2017-2028)
7.2.2 Europe Irbesartan Revenue by Application (2017-2028)
7.3 Europe Irbesartan Market Size by Country
7.3.1 Europe Irbesartan Sales by Country (2017-2028)
7.3.2 Europe Irbesartan Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Irbesartan Market Size by Type
8.1.1 Asia Pacific Irbesartan Sales by Type (2017-2028)
8.1.2 Asia Pacific Irbesartan Revenue by Type (2017-2028)
8.2 Asia Pacific Irbesartan Market Size by Application
8.2.1 Asia Pacific Irbesartan Sales by Application (2017-2028)
8.2.2 Asia Pacific Irbesartan Revenue by Application (2017-2028)
8.3 Asia Pacific Irbesartan Market Size by Region
8.3.1 Asia Pacific Irbesartan Sales by Region (2017-2028)
8.3.2 Asia Pacific Irbesartan Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Irbesartan Market Size by Type
9.1.1 Latin America Irbesartan Sales by Type (2017-2028)
9.1.2 Latin America Irbesartan Revenue by Type (2017-2028)
9.2 Latin America Irbesartan Market Size by Application
9.2.1 Latin America Irbesartan Sales by Application (2017-2028)
9.2.2 Latin America Irbesartan Revenue by Application (2017-2028)
9.3 Latin America Irbesartan Market Size by Country
9.3.1 Latin America Irbesartan Sales by Country (2017-2028)
9.3.2 Latin America Irbesartan Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Irbesartan Market Size by Type
10.1.1 Middle East and Africa Irbesartan Sales by Type (2017-2028)
10.1.2 Middle East and Africa Irbesartan Revenue by Type (2017-2028)
10.2 Middle East and Africa Irbesartan Market Size by Application
10.2.1 Middle East and Africa Irbesartan Sales by Application (2017-2028)
10.2.2 Middle East and Africa Irbesartan Revenue by Application (2017-2028)
10.3 Middle East and Africa Irbesartan Market Size by Country
10.3.1 Middle East and Africa Irbesartan Sales by Country (2017-2028)
10.3.2 Middle East and Africa Irbesartan Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 BMS
11.3.1 BMS Corporation Information
11.3.2 BMS Overview
11.3.3 BMS Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BMS Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BMS Recent Developments
11.4 Sumitomo Dainippon Pharma
11.4.1 Sumitomo Dainippon Pharma Corporation Information
11.4.2 Sumitomo Dainippon Pharma Overview
11.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sumitomo Dainippon Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sumitomo Dainippon Pharma Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Shionogi
11.6.1 Shionogi Corporation Information
11.6.2 Shionogi Overview
11.6.3 Shionogi Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Shionogi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shionogi Recent Developments
11.7 Hanall
11.7.1 Hanall Corporation Information
11.7.2 Hanall Overview
11.7.3 Hanall Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hanall Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hanall Recent Developments
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Corporation Information
11.8.2 Taj Pharmaceuticals Overview
11.8.3 Taj Pharmaceuticals Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Taj Pharmaceuticals Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Taj Pharmaceuticals Recent Developments
11.9 Apotex
11.9.1 Apotex Corporation Information
11.9.2 Apotex Overview
11.9.3 Apotex Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Apotex Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Apotex Recent Developments
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Corporation Information
11.10.2 Jiangsu Hengrui Medicine Overview
11.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Jiangsu Hengrui Medicine Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jiangsu Hengrui Medicine Recent Developments
11.11 Verdant Life Sciences
11.11.1 Verdant Life Sciences Corporation Information
11.11.2 Verdant Life Sciences Overview
11.11.3 Verdant Life Sciences Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Verdant Life Sciences Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Verdant Life Sciences Recent Developments
11.12 Angita Pharma
11.12.1 Angita Pharma Corporation Information
11.12.2 Angita Pharma Overview
11.12.3 Angita Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Angita Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Angita Pharma Recent Developments
11.13 Auro Pharma
11.13.1 Auro Pharma Corporation Information
11.13.2 Auro Pharma Overview
11.13.3 Auro Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Auro Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Auro Pharma Recent Developments
11.14 Avanstra
11.14.1 Avanstra Corporation Information
11.14.2 Avanstra Overview
11.14.3 Avanstra Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Avanstra Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Avanstra Recent Developments
11.15 Zhuhai Rundu Pharma
11.15.1 Zhuhai Rundu Pharma Corporation Information
11.15.2 Zhuhai Rundu Pharma Overview
11.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Zhuhai Rundu Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Zhuhai Rundu Pharma Recent Developments
11.16 Xiansheng Pharmaceutical
11.16.1 Xiansheng Pharmaceutical Corporation Information
11.16.2 Xiansheng Pharmaceutical Overview
11.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Xiansheng Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Xiansheng Pharmaceutical Recent Developments
11.17 CTTQ
11.17.1 CTTQ Corporation Information
11.17.2 CTTQ Overview
11.17.3 CTTQ Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 CTTQ Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 CTTQ Recent Developments
11.18 Tianjin Huairen Pharmaceutical
11.18.1 Tianjin Huairen Pharmaceutical Corporation Information
11.18.2 Tianjin Huairen Pharmaceutical Overview
11.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Tianjin Huairen Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Tianjin Huairen Pharmaceutical Recent Developments
11.19 Jiangsu Wangao Pharmaceutical
11.19.1 Jiangsu Wangao Pharmaceutical Corporation Information
11.19.2 Jiangsu Wangao Pharmaceutical Overview
11.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Jiangsu Wangao Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Jiangsu Wangao Pharmaceutical Recent Developments
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Corporation Information
11.20.2 Zhejiang Huahai Pharmaceutical Overview
11.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Zhejiang Huahai Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.21 Zhejiang Ainuo Pharmaceutical
11.21.1 Zhejiang Ainuo Pharmaceutical Corporation Information
11.21.2 Zhejiang Ainuo Pharmaceutical Overview
11.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Zhejiang Ainuo Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Zhejiang Ainuo Pharmaceutical Recent Developments
11.22 Yuanhe Pharmaceutical
11.22.1 Yuanhe Pharmaceutical Corporation Information
11.22.2 Yuanhe Pharmaceutical Overview
11.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Yuanhe Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Yuanhe Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Irbesartan Industry Chain Analysis
12.2 Irbesartan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Irbesartan Production Mode & Process
12.4 Irbesartan Sales and Marketing
12.4.1 Irbesartan Sales Channels
12.4.2 Irbesartan Distributors
12.5 Irbesartan Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Irbesartan Industry Trends
13.2 Irbesartan Market Drivers
13.3 Irbesartan Market Challenges
13.4 Irbesartan Market Restraints
14 Key Findings in The Global Irbesartan Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer